AAA+ ATPases Reptin and Pontin as potential diagnostic and prognostic biomarkers in salivary gland cancer

AAA+ ATPases Reptin and Pontin as potential diagnostic and prognostic biomarkers in salivary gland cancer - a short report

Published:2018-06-05 Issue:4 Volume:41 Page:455-462
ISSN:2211-3428
Container-title:Cellular Oncology
language:en
Short-container-title:Cell Oncol.

Author:

Mikesch Jan-Henrik,Hartmann Wolfgang,Angenendt Linus,Huber Otmar,Schliemann Christoph,Arteaga Maria Francisca,Wardelmann Eva,Rudack Claudia,Berdel Wolfgang E.,Stenner Markus,Grünewald Inga^ORCID

Funder

Deutsche Forschungsgemeinschaft

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Molecular Medicine,General Medicine

Link

http://link.springer.com/article/10.1007/s13402-018-0382-8/fulltext.html

Reference36 articles.

1. M. Guzzo, L.D. Locati, F.J. Prott, G. Gatta, M. McGurk, L. Licitra, Major and minor salivary gland tumors. Crit Rev Oncol Hematol 74, 134–148 (2010). https://doi.org/10.1016/j.critrevonc.2009.10.004

2. R.J. Zarbo, Salivary gland neoplasia: A review for the practicing pathologist. Mod Pathol 15, 298–323 (2002). https://doi.org/10.1038/modpathol.3880525

3. A. Skalova, D.R. Gnepp, J.S. Lewis Jr., J.L. Hunt, J.A. Bishop, H. Hellquist, A. Rinaldo, V. Vander Poorten, A. Ferlito, Newly described entities in salivary gland pathology. Am J Surg Pathol 41, e33–e47 (2017). https://doi.org/10.1097/PAS.0000000000000883

4. A. Busch, L. Bauer, E. Wardelmann, C. Rudack, I. Grunewald, M. Stenner, Prognostic relevance of epithelial-mesenchymal transition and proliferation in surgically treated primary parotid gland cancer. J Clin Pathol 70, 403–409 (2017). https://doi.org/10.1136/jclinpath-2016-203745

5. I. Grunewald, M. Trautmann, A. Busch, L. Bauer, S. Huss, P. Schweinshaupt, C. Vollbrecht, M. Odenthal, A. Quaas, R. Buttner, M.F. Meyer, D. Beutner, K.B. Huttenbrink, E. Wardelmann, M. Stenner, W. Hartmann, MDM2 and CDK4 amplifications are rare events in salivary duct carcinomas. Oncotarget 7, 75261–75272 (2016). https://doi.org/10.18632/oncotarget.12127

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel LINC02321 promotes cell proliferation and decreases cisplatin sensitivity in bladder cancer by regulating RUVBL2;Translational Oncology;2024-07

2. RUVBL1 in Clear-Cell Renal Cell Carcinoma: Unraveling Prognostic Significance and Correlation with HIF1A;Cancers;2024-03-25

3. RUVBL1/2 Complex in Cancer: Emerging Mechanisms and Therapeutic Opportunities;Interdisciplinary Cancer Research;2024

4. A Systematic Analysis Reveals the Prognostic and Immunological Role of Reptin/RUVBL2 in Human Tumors;Frontiers in Genetics;2022-06-08

5. Low‐density lipoprotein receptor (LDLR) is an independent adverse prognostic factor in acute myeloid leukaemia;British Journal of Haematology;2020-06-08